James E. Dentzer
2013 - Dicerna Pharmaceuticals
In 2013, James E. Dentzer earned a total compensation of $957.4K as Chief Financial Officer at Dicerna Pharmaceuticals.
Compensation breakdown
| Bonus | $45,000 |
|---|---|
| Non-Equity Incentive Plan | $9,235 |
| Option Awards | $882,813 |
| Salary | $20,401 |
| Total | $957,449 |
Dentzer received $882.8K in option awards, accounting for 92% of the total pay in 2013.
Dentzer also received $45K in bonus, $9.2K in non-equity incentive plan and $20.4K in salary.
Rankings
In 2013, James E. Dentzer's compensation ranked 6,829th out of 12,286 executives tracked by ExecPay. In other words, Dentzer earned more than 44.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,829 out of 12,286 | 44th |
Division Manufacturing | 2,420 out of 4,612 | 48th |
Major group Chemicals And Allied Products | 730 out of 1,462 | 50th |
Industry group Drugs | 537 out of 1,156 | 54th |
Industry Pharmaceutical Preparations | 429 out of 890 | 52nd |
Source: SEC filing on April 30, 2014.
Dentzer's colleagues
We found three more compensation records of executives who worked with James E. Dentzer at Dicerna Pharmaceuticals in 2013.